Chris Maxwell Wiltshire

Part of Pfizer Inc., Alanex Corp. is a company that develops pharmaceutical products. The company is based in San Diego, CA. Alanex was acquired by Agouron Pharmaceuticals LLC on May 23, 1997 for $63 million.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Part of Pfizer Inc., Pfizer (La Jolla) is a company that provides research services. The company is based in San Diego, CA. The company was founded by Michael R. Jirousek.

Bionevia Pharmaceuticals, Inc. operates as a chronic disease hospital. Timothy Joseph Barberich has been the CEO of the American company since 2008.

MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany.

Oncotartis LLC engages in the development of anti-cancer drugs. It develops drugs to treat prostrate and breast cancer, melanoma, leukemia and lymphoma. The company was founded by Alexander Polinsky, Andrei Gudkov, and Olga Chernova in 2011 and is headquartered in Buffalo, NY.

MirImmune, Inc. is a biopharmaceutical company that develops new generation immunotherapies for cancer. It combines two approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies. The company was founded by Alexey V. Eliseev, Alexey Wolfson, and Timothy Joseph Barberich on May 18, 2015 and is headquartered in Boston, MA.

Oncotartis, Inc. operates as a biotechnology company. The company was founded by Andrei Gudkov, Alexander Polinsky and Olga Chernova in 2011 and is headquartered in Buffalo, NY.

Founded in 2003, Maxwell Asset Management LLC is a venture capital firm located in Boston. The firm is a subsidiary of Moscow-based Maxwell Capital Group LLC. They manage the Maxwell Biotech Venture Fund, Russia's first venture fund focused on the medical and biotechnology sectors. The fund is one of the first venture funds formed with the participation of the Russian Venture Company (RVC), a fund-of-funds created by the Russian government to promote the development of the venture capital industry and an innovation-based economy.

Boston BioCom LLC develops and commercializes life science technologies. The company was founded by Alexey V. Eliseev in 2007 is headquartered in Boston, MA.